Patent · US Expired

Method of promoting stem cell proliferation or survival by contacting a cell with a stem cell factor-like polypeptide

US6824973B2 · kind B2 · utility

35Cited by
0References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 28, 2001
Grant dateNov 30, 2004
Priority date
Expiry dateJun 28, 2021

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/975
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human stem cell growth factor-like protein. These polynucleotides comprise nucleic acid sequences isolated from cDNA libraries from human testis cells (Hyseq clone identification numbers 2880984 and 2881695), from human fetal skin (Hyseq clone identification number 15375176), adult spleen (Hyseq clone identification number 14856094), and human endothelial cells (Hyseq clone identification numbers 13804756, 13687487, 13804756). Other aspects of the invention include vectors containing processes for producing novel human stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.